| Euronext Paris: GBT
Guerbet SA engages in research, development and manufacturing and sale of contrast agents for medical imaging. It innovates, develops, and manufactures contrast products and injection systems. Guerbet offers contrast products for MRI, X-Ray and interventional radiology. Its contrast products are essential for diagnosis, therapeutic decisions (surgical, medical or other), as well as for individualized monitoring of the efficacy of the proposed treatment. The company provides its services to hospitals, radiologists, cardiologists and wholesale dealers, who supply medicines to pharmacies. Guerbet was founded by André Guerbet in 1926 and is headquartered in Villepinte, France.